Home | xLM's ContinuousTV Weekly Newsletter

#094: GxP in the Age of AI: From AstraZeneca's Head of Digital Strategy (LinkedIn Live event)

Our recent LinkedIn Live, “GxP in the Age of AI: Real-World Perspectives from Pharma IT and Manufacturing,” resonated beyond expectations. The session attracted 624 registrations, all organic. This led to 393 unique viewers and a healthy engagement rate for a technical, unscripted discussion on AI in GxP environments.

Nagesh Nama, +1

•

Feb 4, 2026

Continuous Intelligent Validation

#093: Continuous Intelligent Validation (cIV): From Months of Manual Validation to Minutes of Intelligent Execution

Continuous Intelligent Validation (cIV) was built to break this cycle. Powered by agentic AI and grounded in regulatory rigor, cIV transforms validation from a slow, document-centric obligation into a continuous, intelligent, and scalable capability.

Nagesh Nama, +1

•

Jan 28, 2026

#092: Unscripted LinkedIn Live: GxP AI Implementations @ AstraZeneca

Instead of presentations or slides, the conversation will focus on practical, experience-driven topics. Mr. Bob Buhlmann has engaged directly with global health authorities including FDA, EMA, MHRA, MPA, and NMPA, making his perspective relevant for organizations operating across regions.

Nagesh Nama, +1

•

Jan 21, 2026

cIGA - Continuous Intelligent GxP Auditor

#091: Reengineering Vendor Audits for the AI Era

GxP vendor audits have long been limited by human availability, manual workflows, and post-audit compliance discovery. As life sciences organizations expand their vendor ecosystems, the traditional audit model based on on-site visits, SME-driven interviews, and manually intensive evidence review fails to scale.

Nagesh Nama, +1

•

Jan 15, 2026

xLM's ContinuousTV Weekly Newsletter

•

Oct 29, 2025